secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001193125-26-076609
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q4 revenue $61.5M (-1% YoY); full year net loss includes $196.1M goodwill impairment
--------------------------------------------------------------------------------

- Q4 revenue $61.5M vs $62.3M prior year; adjusted EBITDA $18.0M (29% margin) vs $17.5M (28%).
- Full year 2025 revenue $241.5M vs $252.2M; adjusted net income $34.9M vs $55.1M.
- Net loss for full year 2025 was $199.3M, including $196.1M goodwill impairment; prior year loss $591.4M with $688.9M impairment.
- Q1 2026 revenue guidance $54–56M; full year 2026 revenue guidance $220–226M, below 2025 actual of $241.5M.
- Customer wins: large health system for Population Intelligence; global rare disease firm for US market expansion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000119312526076609/0001193125-26-076609-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000119312526076609/dh-20260226.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-076609

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer